Achtung! Das Lehrangebot ist noch nicht vollständig und wird bis Semesterbeginn laufend ergänzt.
140253 SE VM6 / VM8 - Globalisation, Emerging and Re-Emerging infectious and zoonatic Diseases (2016W)
Preparedness for, response and control of disease outbreaks, epidemics, and pandemics, in the context of climate change, globalization, and gaps in health systems
Prüfungsimmanente Lehrveranstaltung
Labels
SGU
An/Abmeldung
Hinweis: Ihr Anmeldezeitpunkt innerhalb der Frist hat keine Auswirkungen auf die Platzvergabe (kein "first come, first served").
- Anmeldung von Mo 12.09.2016 10:00 bis Mi 28.09.2016 10:00
- Anmeldung von Do 29.09.2016 10:00 bis Mo 03.10.2016 14:00
- Abmeldung bis Mo 31.10.2016 23:59
Details
max. 25 Teilnehmer*innen
Sprache: Englisch
Lehrende
Termine (iCal) - nächster Termin ist mit N markiert
- Dienstag 11.10. 12:00 - 14:00 Seminarraum SG2 Internationale Entwicklung, Sensengasse 3, Bauteil 1
- Dienstag 18.10. 12:00 - 14:00 Seminarraum SG2 Internationale Entwicklung, Sensengasse 3, Bauteil 1
- Dienstag 25.10. 12:00 - 14:00 Seminarraum SG2 Internationale Entwicklung, Sensengasse 3, Bauteil 1
- Dienstag 08.11. 12:00 - 14:00 Seminarraum SG2 Internationale Entwicklung, Sensengasse 3, Bauteil 1
- Dienstag 15.11. 12:00 - 14:00 Seminarraum SG2 Internationale Entwicklung, Sensengasse 3, Bauteil 1
- Dienstag 22.11. 12:00 - 14:00 Seminarraum SG2 Internationale Entwicklung, Sensengasse 3, Bauteil 1
- Dienstag 29.11. 12:00 - 14:00 Seminarraum SG2 Internationale Entwicklung, Sensengasse 3, Bauteil 1
- Dienstag 06.12. 12:00 - 14:00 Seminarraum SG2 Internationale Entwicklung, Sensengasse 3, Bauteil 1
- Dienstag 13.12. 12:00 - 14:00 Seminarraum SG2 Internationale Entwicklung, Sensengasse 3, Bauteil 1
- Dienstag 10.01. 12:00 - 14:00 Seminarraum SG2 Internationale Entwicklung, Sensengasse 3, Bauteil 1
- Dienstag 17.01. 12:00 - 14:00 Seminarraum SG2 Internationale Entwicklung, Sensengasse 3, Bauteil 1
- Dienstag 24.01. 12:00 - 14:00 Seminarraum SG2 Internationale Entwicklung, Sensengasse 3, Bauteil 1
- Dienstag 31.01. 12:00 - 14:00 Seminarraum SG2 Internationale Entwicklung, Sensengasse 3, Bauteil 1
Information
Ziele, Inhalte und Methode der Lehrveranstaltung
Art der Leistungskontrolle und erlaubte Hilfsmittel
Course readings
Materials include: Exercises, readings, videos (e.g., open markets and selling of game meat; farms and Ecoli infected agricultural products).
Materials include: Exercises, readings, videos (e.g., open markets and selling of game meat; farms and Ecoli infected agricultural products).
Mindestanforderungen und Beurteilungsmaßstab
The objectives of this course are:
1. Discuss the theoretical framework for global health and development, in the context of diseases. This course will enable one to understand context and the situational analysis of emerging and re-emerging infectious diseasesand zoonoses
2. To understand risk and risk behaviurs in the outbreak f diseases . this will help one be able to learn about skills development in research and risk assessment
1. Discuss the theoretical framework for global health and development, in the context of diseases. This course will enable one to understand context and the situational analysis of emerging and re-emerging infectious diseasesand zoonoses
2. To understand risk and risk behaviurs in the outbreak f diseases . this will help one be able to learn about skills development in research and risk assessment
Prüfungsstoff
Literatur
Global report on Diabetes, WHO, Geneva, 2016
The Global Burden of Hepatitis E Virus Genotypes 1 and 2 in 2005.
Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. Hepatology, Vol. 55, No. 4, 2012: 988-997
Global, regional, and national agesex specific all-cause and cause-specific mortality for 240 causes of death, 19902013: a systematic analysis for the Global Burden of Disease Study 2013
GBD 2013 Mortality and Causes of Death Collaborators. Lancet. 2015;385(9963):11771
Emerging and re- emerging infections in India: an overview, Journal of Biosciences: 2008
Development of a One Health National Capacity in Africa, Curr Top Microbiology Immunolgy, 2013
Knecht, D., Popiolek, M. & Zalesny, G., 2011. Does meatiness of pigs depend on the level of gastro-intestinal parasites infection? Preventive veterinary medicine, 99(2-4), pp.2349. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21334086.
Roepstorff, A. et al., 2011. Helminth parasites in pigs: new challenges in pig production and current research highlights. Veterinary parasitology, 180(1-2), pp.7281. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21684689.
Projections of Global mortality and burden of disease from 2002 to 2030
Global Action Plan for the prevention and control of NCDs 2013-2020, WHO , Geneva, 2013
GBN 2013, mortality and causes of Death. Collaborators: Lancet, 2015; 385 (9963):117-71
Global , regional and national age-sex specific m all cause and cause specific mortality for 240 causes f death; 1990-2013: a systematic analysis for the Global burden of disease study 2013
The Danish Zoonosis centre n pigs and human infections (established 1994)Websites
WHO/-www.who.org
OHCEA/www.ohcea.org
SEAHOUN-www.sehoun.org
FAO/www.fao.org
CDC/www.cdc.org
UN/www.unhcr.org
Idf.org/membership/afr/Uganda
https://www.cdc.gov/hf/ebola
The Global Burden of Hepatitis E Virus Genotypes 1 and 2 in 2005.
Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. Hepatology, Vol. 55, No. 4, 2012: 988-997
Global, regional, and national agesex specific all-cause and cause-specific mortality for 240 causes of death, 19902013: a systematic analysis for the Global Burden of Disease Study 2013
GBD 2013 Mortality and Causes of Death Collaborators. Lancet. 2015;385(9963):11771
Emerging and re- emerging infections in India: an overview, Journal of Biosciences: 2008
Development of a One Health National Capacity in Africa, Curr Top Microbiology Immunolgy, 2013
Knecht, D., Popiolek, M. & Zalesny, G., 2011. Does meatiness of pigs depend on the level of gastro-intestinal parasites infection? Preventive veterinary medicine, 99(2-4), pp.2349. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21334086.
Roepstorff, A. et al., 2011. Helminth parasites in pigs: new challenges in pig production and current research highlights. Veterinary parasitology, 180(1-2), pp.7281. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21684689.
Projections of Global mortality and burden of disease from 2002 to 2030
Global Action Plan for the prevention and control of NCDs 2013-2020, WHO , Geneva, 2013
GBN 2013, mortality and causes of Death. Collaborators: Lancet, 2015; 385 (9963):117-71
Global , regional and national age-sex specific m all cause and cause specific mortality for 240 causes f death; 1990-2013: a systematic analysis for the Global burden of disease study 2013
The Danish Zoonosis centre n pigs and human infections (established 1994)Websites
WHO/-www.who.org
OHCEA/www.ohcea.org
SEAHOUN-www.sehoun.org
FAO/www.fao.org
CDC/www.cdc.org
UN/www.unhcr.org
Idf.org/membership/afr/Uganda
https://www.cdc.gov/hf/ebola
Zuordnung im Vorlesungsverzeichnis
VM6 / VM8
Letzte Änderung: Mi 21.04.2021 13:31
The role of the World Health Organization, its definition of health, international health regulations, policies and strategies.
Factors influencing transmission and epidemiological patterns, climate change and pathogen emergence
One health (one medicine) approaches to the problem of emerging and re-merging infectious and zoonotic diseases
Health policiesThe course will focus particularly on the following elements:
1. Globalization, health and development: Non communicable diseases, pandemics and epidemics
2. Types: Emerging, re-emerging infectious, and zoonotic diseases
3. Factors contributing to spread of emerging and zoonotics and mapping of geographical distribution of diseases
4. World Health Organisation regulations, Biosecurity and zoonotic diseases
5. Vaccines, diagnostics, and antimicrobial agents in control of communicable diseases
(a) Vaccine development (big companies and trials /common community beliefs)
(b) Diagnostics , treatment and control
6. Antimicrobial resistance
(a) Magnitude of the antimicrobial resistance (consumption of medicines off the pharmaceutical counters especially antibiotics by humans and animals)
(b) Impact of agriculture practice (ecosystems, biodiversity and host parasites)
(c) Impact of veterinary and animal husbandry practice (living next to game reserves and poaching or rearing domestic animals in close range with wildlife)
7. Health systems in control of outbreaks, epidemics, and pandemics
(a) Preparedness for and response to disease outbreaks
(b) Health System Strengthening
(c) Public health measures and control of outbreaks, epidemics, and pandemics
(d) One Health approaches to the problem of emerging and re-emerging zoonotic diseases (OHCEA/Asian based SEAHOUN organisations to prevent public health pandemics)-and-Eco-health initiatives
8. Community mobilization for control of outbreaks, epidemics, and pandemics
(a) Community health workers in Disease surveillance and response
(b) Health and Social protection /community insurances
(c) Community participatory approaches research applications to emerging zoonotic diseases (using of focus group discussions, key informants, in depth interviews and observation in studying anthrax in the soil, rabies due to stray dogs in cities and rural communities and others)
9. Emerging pandemic threats and infectious disease risks: risk behaviours and assessment, and risk communication (behavioural model analysis)
10. Occupational health and safety, Climate change (road accidents, fires, and gendered hurricanes like Katrina in New Orleans), Climate change adaptation and emerging zoonotic diseases
11. Use of HIV/AIDS model for treatment of other diseases e.g., at health facilities where peer groups and expert patients help with treatment and sharing of health information e,g., for NCDs like Type 2 Diabetes etc)
12. Institutions that respond to emerging infectious and zoonotic diseases.